Sökning: WFRF:(Mont Lluís)
> (2020-2024) >
Anticoagulation wit...
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
-
- Becher, Nina (författare)
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany
-
- Toennis, Tobias (författare)
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany
-
- Bertaglia, Emanuele (författare)
- Department of Cardiac, Vascular, Thoracic and Public Health Sciences, Azienda Ospedaliera, Padua, Italy
-
visa fler...
-
- Blomström-Lundqvist, Carina (författare)
- Örebro universitet,Institutionen för medicinska vetenskaper,Department of Medical Science, Uppsala University, Uppsala, Sweden; Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
-
- Brandes, Axel (författare)
- Department of Cardiology, Esbjerg Hospital - University Hospital of Southern Denmark, Esbjerg, and Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
-
- Cabanelas, Nuno (författare)
- Cardiology Department, Fernando Fonseca Hospital, Amadora, Portugal
-
- Calvert, Melanie (författare)
- Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, United Kingdom; NIHR Birmingham Biomedical Research Centre and NIHR Applied Research Collaboration West Midlands, University of Birmingham, Edgbaston, Birmingham, UK
-
- Camm, A. John (författare)
- Cardiovascular and Cell Sciences Research Institute, St George's, University of London, and Imperial College, London, United Kingdom
-
- Chlouverakis, Gregory (författare)
- Biostatistics Lab, School of Medicine, University of Crete, Crete, Greece
-
- Dan, Gheorghe-Andrei (författare)
- Medicine University "Carol Davila", Colentina University Hospital, Bucharest, Romania
-
- Dichtl, Wolfgang (författare)
- Department of Internal Medicine III, Cardiology and Angiology, Innsbruck Medical University, Innsbruck, Austria
-
- Diener, Hans Christoph (författare)
- Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Duisburg-Essen, Essen, Germany
-
- Fierenz, Alexander (författare)
- Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Germany
-
- Goette, Andreas (författare)
- Department of Cardiology and Intensive Care Medicine, St Vincenz-Hospital Paderborn, Paderborn, Germany; Atrial Fibrillation NETwork (AFNET), Muenster, Germany
-
- de Groot, Joris R. (författare)
- Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
-
- Hermans, Astrid N. L. (författare)
- Departments of Cardiology and Physiology, Maastricht University, Maastricht, The Netherlands
-
- Lip, Gregory Y. H. (författare)
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; and Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
-
- Lubinski, Andrzej (författare)
- Medical University of Gdańsk, Department of Cardiology and Internal Diseases, Gdańsk, Poland
-
- Marijon, Eloi (författare)
- Cardiology Division, European Georges Pompidou Hospital, Paris, France
-
- Merkely, Béla (författare)
- Heart and Vascular Centre, Semmelweis University, Budapest, Hungary
-
- Mont, Lluís (författare)
- Hospital Clinic, Universtitat de Barcelona, Catalonia, Spain; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; Centro de Investigacion Biomedica en Red Cardiovascular (CIBERCV), Madrid, Spain
-
- Ozga, Ann-Kathrin (författare)
- Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Germany
-
- Rajappan, Kim (författare)
- Cardiac Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
-
- Sarkozy, Andrea (författare)
- HRMC, University Hospital Brussels, VUB, Belgium
-
- Scherr, Daniel (författare)
- Department of Cardiology, University Hospital Graz, Austria
-
- Schnabel, Renate B (författare)
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany
-
- Schotten, Ulrich (författare)
- Departments of Cardiology and Physiology, Maastricht University, Maastricht, The Netherlands; Atrial Fibrillation NETwork (AFNET), Muenster, Germany
-
- Sehner, Susanne (författare)
- Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Germany
-
- Simantirakis, Emmanuel (författare)
- Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece
-
- Vardas, Panos (författare)
- Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece; Biomedical Research Foundation Academy of Athens (BRFAA), Greece and Hygeia Hospitals Group, Athens, Greece
-
- Velchev, Vasil (författare)
- Cardiology Clinic, St. Anna University Hospital, Medical University Sofia, Sofia, Bulgaria
-
- Wichterle, Dan (författare)
- Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia
-
- Zapf, Antonia (författare)
- Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Germany
-
- Kirchhof, Paulus (författare)
- Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany; Atrial Fibrillation NETwork (AFNET), Muenster, Germany
-
NOAH-AFNET, - (bidragsgivare)
-
visa färre...
-
(creator_code:org_t)
- Oxford University Press, 2024
- 2024
- Engelska.
-
Ingår i: European Heart Journal. - : Oxford University Press. - 0195-668X .- 1522-9645. ; 45:10, s. 837-849
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND AND AIMS: Patients with long atrial high-rate episodes (AHRE) ≥ 24 hours and stroke risk factors are often treated with anticoagulation for stroke prevention. Anticoagulation has never been compared to no anticoagulation in these patients.METHODS: This secondary prespecified analysis of NOAH-AFNET 6 examined interactions between AHRE duration at baseline and anticoagulation with edoxaban compared to placebo in patients with AHRE and stroke risk factors. The primary efficacy outcome was a composite of stroke, systemic embolism, or cardiovascular death. The safety outcome was a composite of major bleeding and death. Key secondary outcomes were components of these outcomes and ECG-diagnosed atrial fibrillation.RESULTS: AHRE ≥24 hours were present at baseline in 259/2389 patients enrolled in NOAH-AFNET 6 (11%, 78 ± 7 years old, 28% women, CHA2DS2-VASc score 4). Clinical characteristics were not different from patients with shorter AHRE. During a median follow-up of 1.8 years, the primary outcome occurred in 9/132 patients with AHRE ≥24 hours (4.3%/patient-year, 2 strokes) treated with anticoagulation and in 14/127 patients treated with placebo (6.9%/patient-year, 2 strokes). AHRE duration did not interact with the efficacy (p-interaction = 0.65) or safety (p-interaction = 0.98) of anticoagulation. Analyses including AHRE as a continuous parameter confirmed this. Patients with AHRE ≥24 hours developed more ECG-diagnosed atrial fibrillation (17.0%/patient-year) than patients with shorter AHRE (8.2%/patient-year; p < 0.001).CONCLUSIONS: This hypothesis-generating analysis does not find an interaction between AHRE duration and anticoagulation therapy in patients with device-detected AHRE and stroke risk factors. Further research is needed to identify patients with long AHRE at high stroke risk.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- NOAH-AFNET 6
- atrial fibrillation
- atrial high-rate episodes
- stroke
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Becher, Nina
-
Toennis, Tobias
-
Bertaglia, Emanu ...
-
Blomström-Lundqv ...
-
Brandes, Axel
-
Cabanelas, Nuno
-
visa fler...
-
Calvert, Melanie
-
Camm, A. John
-
Chlouverakis, Gr ...
-
Dan, Gheorghe-An ...
-
Dichtl, Wolfgang
-
Diener, Hans Chr ...
-
Fierenz, Alexand ...
-
Goette, Andreas
-
de Groot, Joris ...
-
Hermans, Astrid ...
-
Lip, Gregory Y. ...
-
Lubinski, Andrze ...
-
Marijon, Eloi
-
Merkely, Béla
-
Mont, Lluís
-
Ozga, Ann-Kathri ...
-
Rajappan, Kim
-
Sarkozy, Andrea
-
Scherr, Daniel
-
Schnabel, Renate ...
-
Schotten, Ulrich
-
Sehner, Susanne
-
Simantirakis, Em ...
-
Vardas, Panos
-
Velchev, Vasil
-
Wichterle, Dan
-
Zapf, Antonia
-
Kirchhof, Paulus
-
NOAH-AFNET, -
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Heart J ...
- Av lärosätet
-
Örebro universitet